An Update On Renal Denervation For Resistant Hypertension: It Really Works As Shown By RCTs: What Are The Techniques And Devices: When Should They Be Used

Renal Artery Denervation Is Back: New Evidence; New Devices, New Applications And Adjuncts (Sensors And Feeback Loops) To Facilitate The Treatment: Why Does It Work And When Should It Be Used

What Are The Molecular Mechanisms Underlying Carotid And Coronary Plaque Rupture: Can They Be Modified By Drugs In The Future

The Outcomes Of Major Vascular Procedures Are Better In Fat Than Thin Patients: What Is The Basis For This Obesity Paradox And Should It Influence Treatment: Thin May Be In, But Fat Is Where It’s At

Congestive Heart Failure And A Low Ejection Fraction Negatively Influence The Duration Of Patency Following Lower Extremity Bypasses: What To Do About It

New Developments In Methods To Prevent Kidney Damage From Iodinated Contrast Agents: Are Any Drugs Truly Protective

How To Manage Patients With Recent Coronary DESs Who Require Vascular Operations Or Interventions: What To Do About Antiplatelet Medications: How Long To Wait Before Stopping Safely: What To Do With Urgent Or Emergent Cases To Avoid DES Thrombosis

Expanding Endovascular Renal Artery Denervation To Multiorgan Arterial Denervation: What Are Its Potential Benefits In Treating Human Diseases: What Is The Supporting Evidence

Managing Postoperative Anemia After Major Vascular Surgery: Late Breaking Results From The TOP Trial Show What Is Best

Panel Discussion

Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)